NCT05062031View on ClinicalTrials.gov

Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops

NAActive, not recruitingINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Myopia
Interventions
DEVICE

Defocus Incorporated Multiple Segments® (DIMS®) lenses

Daily wear for 24 months. Lenses have a central monofocal optical zone correcting spherical or spherocylindrical ametropia, surrounded by a ring made up of 300 defocusing pellets. This lens geometry reduces the phenomenon of blurred image projected in the retinal periphery, encountered when myopic eyes are corrected with monofocal lenses.

DRUG

Atropine 0.05% eyedrops

One drop each evening in both eyes for 24 months.

DEVICE

Monofocal lenses

Daily wear for 24 months

Trial Locations (1)

75019

Hôpital Fondation Adolphe de Rothschild, Paris

All Listed Sponsors
collaborator

Ecouter Voir

UNKNOWN

collaborator

Hoya Lens France

UNKNOWN

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK